B
Benedicte Parm Ulhøi
Researcher at Aarhus University Hospital
Publications - 70
Citations - 3053
Benedicte Parm Ulhøi is an academic researcher from Aarhus University Hospital. The author has contributed to research in topics: Cancer & Prostate cancer. The author has an hindex of 25, co-authored 56 publications receiving 2462 citations. Previous affiliations of Benedicte Parm Ulhøi include Aarhus University.
Papers
More filters
Journal ArticleDOI
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
Jakob Hedegaard,Philippe Lamy,Iver Nordentoft,Ferran Algaba,Søren Høyer,Benedicte Parm Ulhøi,Søren Vang,Thomas Reinert,Gregers G. Hermann,Karin Mogensen,Mathilde Borg Houlberg Thomsen,Morten Muhlig Nielsen,Mirari Marquez,Ulrika Segersten,Mattias Aine,Mattias Höglund,Karin Birkenkamp-Demtröder,Niels Fristrup,Michael Borre,Arndt Hartmann,Robert Stöhr,Sven Wach,Bastian Keck,Anna Katharina Seitz,Roman Nawroth,Tobias Maurer,Cane Tulic,Tatjana Simic,Kerstin Junker,Marcus Horstmann,Niels Harving,Astrid Christine Petersen,M. Luz Calle,Ewout W. Steyerberg,Willemien Beukers,Kim E.M. van Kessel,Jørgen Bjerggaard Jensen,Jakob Skou Pedersen,Per-Uno Malmström,Núria Malats,Francisco X. Real,Ellen C. Zwarthoff,Torben F. Ørntoft,Lars Dyrskjøt +43 more
TL;DR: A comprehensive transcriptional analysis of 460 early-stage urothelial carcinomas revealed frequent mutations in genes encoding proteins involved in chromatin organization and cytoskeletal functions and suggested the identification of subclasses in NMIBC may offer better prognostication and treatment selection based on subclass assignment.
Journal ArticleDOI
Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro.
Lars Dyrskjøt,Marie Stampe Ostenfeld,Jesper B. Bramsen,Asli Silahtaroglu,Philippe Lamy,Ramshanker Ramanathan,Niels Fristrup,Jens Ledet Jensen,Claus L. Andersen,Karsten Zieger,Sakari Kauppinen,Benedicte Parm Ulhøi,Jørgen Kjems,Michael Borre,Torben F. Ørntoft +14 more
TL;DR: The findings reported here indicate that several miRNAs are differentially regulated in bladder cancer and may form a basis for clinical development of new biomarkers for bladder cancer.
Journal ArticleDOI
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer.
Anne Birgitte Als,Lars Dyrskjøt,Hans von der Maase,Karen Koed,Francisco Mansilla,Helle Toldbod,Jens Ledet Jensen,Benedicte Parm Ulhøi,Lisa Sengeløv,Klaus Møller-Ernst Jensen,Torben F. Ørntoft +10 more
TL;DR: Emmprin and survivin proteins were identified as strong independent prognostic factors for response and survival after cisplatin-containing chemotherapy in patients with advanced bladder cancer.
Journal ArticleDOI
The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial
Pernille Lassen,Jesper Grau Eriksen,Annelise Krogdahl,Marianne Hamilton Therkildsen,Benedicte Parm Ulhøi,Marie Overgaard,Lena Specht,Elo Andersen,Jørgen Johansen,Lisbeth Juhler Andersen,Cai Grau,Jens Overgaard +11 more
TL;DR: The observed benefit is independent of tumour p16-status and the use of a moderately accelerated radiotherapy regimen seems advantageous also for HPV/p16-positive HNSCC.
Journal ArticleDOI
TLR3 deficiency renders astrocytes permissive to herpes simplex virus infection and facilitates establishment of CNS infection in mice
Line S. Reinert,Louis Andreas Harder,Christian K. Holm,Marie B. Iversen,Kristy A. Horan,Frederik Dagnæs-Hansen,Benedicte Parm Ulhøi,Thomas Hellesøe Holm,Trine H. Mogensen,Trevor Owens,Jens R. Nyengaard,Allan Randrup Thomsen,Søren R. Paludan +12 more
TL;DR: It is shown that in mice TLR3 provides early control of HSV-2 infection immediately after entry into the CNS by mediating type I IFN responses in astrocytes, possibly preventing HSV from spreading beyond the neurons mediating entry intoThe CNS.